Product Information
GLYBURIDE 1.25 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.0689 per EA under NDC 75834020201. Its NADAC has been published 282 times since Oct 16, 2019.
FDA first approved this application on Jan 4, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.25 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834020201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
GLYBURIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203379FDA Approved
1/4/2019
TE Code
AB1
On Market Since
1/25/2019
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE 1.25 MG TABLET has been published 282 times since Oct 16, 2019, and over the history we have for it it has declined 39.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0689 per EA |
|---|---|
| All-time high | $0.1443 (Dec 11, 2019) |
| All-time low | $0.0561 (Jun 19, 2024) |
| Median price | $0.0848 |
| Average price | $0.0888 |
| Largest weekly change | +60.2% (Nov 22, 2023) |
| Weeks tracked | 282 |
| Tracking since | Oct 16, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-1.5%
5Y
-37.7%
All
-39.3%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nivagen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
GLYBURIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonylurea class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYBURIDE 1.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE 1.25 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.0689 per EA (NDC 75834020201), effective Mar 5, 2025.
How has the price of GLYBURIDE 1.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYBURIDE 1.25 MG TABLET has declined 39.3%. It has been tracked across 282 weekly CMS publications since Oct 16, 2019.
What are the highest and lowest recorded NADAC prices for GLYBURIDE 1.25 MG TABLET?
Since Oct 16, 2019, the NADAC for GLYBURIDE 1.25 MG TABLET has ranged from a low of $0.0561 (Jun 19, 2024) to a high of $0.1443 (Dec 11, 2019), with a median of $0.0848 per EA.
Are there cheaper alternatives to GLYBURIDE 1.25 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYBURIDE 1.25 MG TABLET, is $0.0606 per EA — about 12% below GLYBURIDE 1.25 MG TABLET.
Who manufactures GLYBURIDE 1.25 MG TABLET?
GLYBURIDE 1.25 MG TABLET (NDC 75834020201) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.